Genetic testing company 23andMe says it is complying with a Food and Drug Administration directive to stop selling health-related genetic tests during a regulatory review.

The Mountain View, Calif., company said late Thursday that it will continue to provide ancestry-related information to customers and raw genetic data without interpretation. Customers who bought kits since the FDA order came out last month will be eligible for refunds.

23andMe Inc. sells the health-related tests as a way to help users predict their risk of developing various diseases. But last month, the FDA ordered the company to stop sales. It says 23andMe has failed to show that the technology is supported by science.

23andMe sells its tests online. Customers receive a small tube in the mail, which they return to the company with a saliva sample for DNA analysis.